WO2002064761A3 - Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein - Google Patents

Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein Download PDF

Info

Publication number
WO2002064761A3
WO2002064761A3 PCT/EP2002/001260 EP0201260W WO02064761A3 WO 2002064761 A3 WO2002064761 A3 WO 2002064761A3 EP 0201260 W EP0201260 W EP 0201260W WO 02064761 A3 WO02064761 A3 WO 02064761A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
fatty acid
long chain
polyunsaturated fatty
chain polyunsaturated
protein
Prior art date
Application number
PCT/EP2002/001260
Other languages
French (fr)
Other versions
WO2002064761A2 (en )
Inventor
Zhimin Zhu
Original Assignee
Bayer Ag
Zhimin Zhu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Abstract

Reagents that regulate human long chain polyunsaturated fatty acid elongation enzyme-like protein and reagents which bind to human long chain polyunsaturated fatty acid elongation enzyme-like gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, diabetes, CNS disorder, metabolic disease, asthma or COPD.
PCT/EP2002/001260 2001-02-09 2002-02-07 Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein WO2002064761A3 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US26741501 true 2001-02-09 2001-02-09
US60/267,415 2001-02-09
US33144901 true 2001-11-16 2001-11-16
US60/331,449 2001-11-16
US33494801 true 2001-12-04 2001-12-04
US60/334,948 2001-12-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2002231779A AU2002231779A1 (en) 2001-02-09 2002-02-07 Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein

Publications (2)

Publication Number Publication Date
WO2002064761A2 true WO2002064761A2 (en) 2002-08-22
WO2002064761A3 true true WO2002064761A3 (en) 2003-05-01

Family

ID=27401965

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/001260 WO2002064761A3 (en) 2001-02-09 2002-02-07 Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein

Country Status (1)

Country Link
WO (1) WO2002064761A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007013479A3 (en) * 2005-07-27 2007-06-28 Oncotherapy Science Inc Genes and polypeptides relating to prostate cancers

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012720A2 (en) * 1998-09-02 2000-03-09 Abbott Laboratories Elongase genes and uses thereof
WO2000070945A2 (en) * 1999-05-20 2000-11-30 Karolinska Innovations Ab Fatty acid elongation genes and uses thereof
WO2001004636A1 (en) * 1999-07-12 2001-01-18 Ohio University Mammalian cells expressing desaturases and elongases
WO2002044320A2 (en) * 2000-11-29 2002-06-06 Xenon Genetics Inc. Human elongase genes and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012720A2 (en) * 1998-09-02 2000-03-09 Abbott Laboratories Elongase genes and uses thereof
WO2000070945A2 (en) * 1999-05-20 2000-11-30 Karolinska Innovations Ab Fatty acid elongation genes and uses thereof
WO2001004636A1 (en) * 1999-07-12 2001-01-18 Ohio University Mammalian cells expressing desaturases and elongases
WO2002044320A2 (en) * 2000-11-29 2002-06-06 Xenon Genetics Inc. Human elongase genes and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 27 January 2000 (2000-01-27), XP002228622, retrieved from EBI Database accession no. AL137506 *
LEONARD AMANDA E ET AL: "Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids", BIOCHEMICAL JOURNAL, PORTLAND PRESS, LONDON, GB, vol. 350, no. 3, 2000, pages 765 - 770, XP002208697, ISSN: 0264-6021 *
OH ET AL: "ELO2 and ELO3, homologs of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 28, 11 July 1997 (1997-07-11), pages 17376 - 17384, XP002119019, ISSN: 0021-9258 *

Also Published As

Publication number Publication date Type
WO2002064761A2 (en) 2002-08-22 application

Similar Documents

Publication Publication Date Title
WO2002062983A1 (en) A yeast with t cell immunoregulatory activity as well as the preparing method and the uses thereof
WO2004072294A3 (en) Methods and means for nucleic acid sequencing
Songer 5. Bovine enteritis and enterotoxaemia
WO2003029457A1 (en) Process for producing amino acid
Ashton Reinventing drug development
CN103621838B (en) Duck increase primiparous premix and methods of using the duck egg weight
WO2003025149A8 (en) Cell populations which co-express cd49c and cd90
RU2006114832A (en) The process of differentiation of stem cells in the induction of myocardial
WO2005077042A3 (en) Albumin fusion proteins
WO2006000448A3 (en) Fc-INTERFERON-BETA FUSION PROTEINS
Salles Genetics of hypophosphosphatemia
WO2002101353A3 (en) Methods and products for analyzing nucleic acids based on methylation status
Shah et al. HISTOCHEMICAL STUDY DURING FOLIAR TO FLORAL DIFFERENTIATION IN SOME MONOCOTYLEDONS I. RICE (ORYZA SATIVA L.)
Ellwood Finding foods that agree with our genes
Rubini et al. Association between MTHFR C. 1298A> C polymorphism in the methylene-tetrahydrofolate (MTHFR) gene and increased risk for rheumatoid arthritis
Zhou et al. Mitochondrial aminoacyl-tRNA synthetases related to human diseases
WO2003055913A3 (en) Secreted protein
RU2002127001A (en) Food product enriched with iron and its production method
RU2009120936A (en) Dosing support girudorefleksoterapii sessions in women with acquired and hereditary thrombophilia
RU2002125292A (en) Automated control and accounting information system sources of anthropogenic emissions and removals of greenhouse gases, the effects of interventions to reduce their levels and assignment progress of operations
WO2004042390A3 (en) Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b)
Cohn Relation Between Pulse Oximetry and Clinical Score in Children with Acute Wheezing less than 24 month of age
CN1423696A (en) Human schizophrenia genes

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
WWW Wipo information: withdrawn in national office

Country of ref document: JP

NENP Non-entry into the national phase in:

Ref country code: JP